Vanguard Capital Wealth Advisors Bristol Myers Squibb CO Transaction History

Vanguard Capital Wealth Advisors

  • $102 Million
  • Q3 2024

A detailed history of Vanguard Capital Wealth Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vanguard Capital Wealth Advisors holds 6,600 shares of BMY stock, worth $384,318. This represents 0.34% of its overall portfolio holdings.

Number of Shares
6,600
Previous 7,500 12.0%
Holding current value
$384,318
Previous $311,000 9.65%
% of portfolio
0.34%
Previous 0.21%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
SELL
$39.66 - $51.75 $35,694 - $46,575
-900 Reduced 12.0%
6,600 $341,000
Q2 2024

Aug 07, 2024
SELL
$40.25 - $52.99 $12,075 - $15,897
-300 Reduced 3.85%
7,500 $311,000
Q1 2024

Apr 15, 2024
SELL
$47.98 - $54.4 $23,990 - $27,200
-500 Reduced 6.02%
7,800 $422,000
Q4 2023

Feb 05, 2024
BUY
$48.48 - $57.85 $208,464 - $248,755
4,300 Added 107.5%
8,300 $425,000
Q2 2023

Jul 14, 2023
SELL
$63.71 - $70.74 $76,452 - $84,888
-1,200 Reduced 23.08%
4,000 $255,000
Q1 2023

Apr 20, 2023
BUY
$65.71 - $74.53 $111,706 - $126,701
1,700 Added 48.57%
5,200 $360,000
Q4 2022

Jan 17, 2023
BUY
$68.48 - $81.09 $239,680 - $283,815
3,500 New
3,500 $0
Q2 2022

Aug 04, 2022
SELL
$72.62 - $79.98 $428,458 - $471,882
-5,900 Reduced 68.6%
2,700 $207,000
Q1 2022

Apr 29, 2022
SELL
$61.48 - $73.72 $67,628 - $81,092
-1,100 Reduced 11.34%
8,600 $628,000
Q4 2021

Feb 02, 2022
BUY
$53.63 - $62.52 $18,770 - $21,882
350 Added 3.74%
9,700 $604,000
Q3 2021

Nov 01, 2021
BUY
$59.17 - $69.31 $122,422 - $143,402
2,069 Added 28.42%
9,350 $553,000
Q2 2021

Jul 28, 2021
SELL
$61.91 - $67.42 $85,064 - $92,635
-1,374 Reduced 15.88%
7,281 $486,000
Q1 2021

Apr 12, 2021
BUY
$59.34 - $66.74 $307,440 - $345,779
5,181 Added 149.14%
8,655 $546,000
Q4 2020

Jan 25, 2021
SELL
$57.74 - $65.43 $159,766 - $181,044
-2,767 Reduced 44.34%
3,474 $215,000
Q2 2020

Aug 05, 2020
SELL
$54.82 - $64.09 $514,376 - $601,356
-9,383 Reduced 60.06%
6,241 $367,000
Q4 2019

Jan 28, 2020
BUY
$49.21 - $64.19 $21,947 - $28,628
446 Added 2.94%
15,624 $1 Million
Q3 2019

Oct 18, 2019
SELL
$42.77 - $50.71 $153,159 - $181,592
-3,581 Reduced 19.09%
15,178 $769,000
Q2 2019

Aug 05, 2019
BUY
$44.62 - $49.34 $41,541 - $45,935
931 Added 5.22%
18,759 $850,000
Q1 2019

Apr 29, 2019
BUY
$45.12 - $53.8 $328,022 - $391,126
7,270 Added 68.86%
17,828 $850,000
Q4 2018

Jan 17, 2019
SELL
$48.76 - $63.23 $84,842 - $110,020
-1,740 Reduced 14.15%
10,558 $548,000
Q3 2018

Oct 19, 2018
BUY
$55.19 - $62.25 $678,726 - $765,550
12,298 New
12,298 $763,000
Q1 2018

Apr 25, 2018
SELL
$59.92 - $68.98 $266,644 - $306,961
-4,450 Closed
0 $0
Q4 2017

Feb 15, 2018
BUY
$59.94 - $65.35 $266,733 - $290,807
4,450
4,450 $0

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Vanguard Capital Wealth Advisors Portfolio

Follow Vanguard Capital Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Capital Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Capital Wealth Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email